AMS Quote, Financials, Valuation and Earnings

Biote has a net margin of -2.96% compared to American Shared Hospital Services's net margin of 7.43%. American Shared Hospital Services's return on equity of 13.75% beat Biote's return on equity of --.

American Shared Hospital Services has a consensus price target of $4.84, signalling upside risk potential of 74.73%. On the other hand Biote has an analysts' consensus of $7.47 which suggests that it could grow by 117.69%. Given that Biote has higher upside potential than American Shared Hospital Services, analysts believe Biote is more attractive than American Shared Hospital Services.

American Shared Hospital Services has a beta of 0.424, which suggesting that the stock is 57.593% less volatile than S&P 500. In comparison Biote has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biote offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. Biote pays out 150.27% of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7M, which are smaller than Biote quarterly revenues of $49.8M. American Shared Hospital Services's net income of -$207K is lower than Biote's net income of $3.7M. Notably, American Shared Hospital Services's price-to-earnings ratio is 7.94x while Biote's PE ratio is 19.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.64x versus 0.60x for Biote. Usually stocks with elevated PS ratios are considered overvalued.

Cryo-Cell International has a net margin of -2.96% compared to American Shared Hospital Services's net margin of 3.55%. American Shared Hospital Services's return on equity of 13.75% beat Cryo-Cell International's return on equity of --.

American Shared Hospital Services has a consensus price target of $4.84, signalling upside risk potential of 74.73%. On the other hand Cryo-Cell International has an analysts' consensus of $8.50 which suggests that it could grow by 50.44%. Given that American Shared Hospital Services has higher upside potential than Cryo-Cell International, analysts believe American Shared Hospital Services is more attractive than Cryo-Cell International.

American Shared Hospital Services has a beta of 0.424, which suggesting that the stock is 57.593% less volatile than S&P 500. In comparison Cryo-Cell International has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.282%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cryo-Cell International offers a yield of 8.85% to investors and pays a quarterly dividend of $0.25 per share. American Shared Hospital Services pays -- of its earnings as a dividend. Cryo-Cell International pays out 502.5% of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7M, which are smaller than Cryo-Cell International quarterly revenues of $8M. American Shared Hospital Services's net income of -$207K is lower than Cryo-Cell International's net income of $282.9K. Notably, American Shared Hospital Services's price-to-earnings ratio is 7.94x while Cryo-Cell International's PE ratio is 565.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.64x versus 1.44x for Cryo-Cell International. Usually stocks with elevated PS ratios are considered overvalued.

Omnicell has a net margin of -2.96% compared to American Shared Hospital Services's net margin of 5.16%. American Shared Hospital Services's return on equity of 13.75% beat Omnicell's return on equity of 1.04%.

American Shared Hospital Services has a consensus price target of $4.84, signalling upside risk potential of 74.73%. On the other hand Omnicell has an analysts' consensus of $50.71 which suggests that it could grow by 69.5%. Given that American Shared Hospital Services has higher upside potential than Omnicell, analysts believe American Shared Hospital Services is more attractive than Omnicell.

American Shared Hospital Services has a beta of 0.424, which suggesting that the stock is 57.593% less volatile than S&P 500. In comparison Omnicell has a beta of 0.785, suggesting its less volatile than the S&P 500 by 21.543%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Omnicell offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. Omnicell pays out -- of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7M, which are smaller than Omnicell quarterly revenues of $306.9M. American Shared Hospital Services's net income of -$207K is lower than Omnicell's net income of $15.8M. Notably, American Shared Hospital Services's price-to-earnings ratio is 7.94x while Omnicell's PE ratio is 110.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.64x versus 1.25x for Omnicell. Usually stocks with elevated PS ratios are considered overvalued.

P3 Health Partners has a net margin of -2.96% compared to American Shared Hospital Services's net margin of -12.84%. American Shared Hospital Services's return on equity of 13.75% beat P3 Health Partners's return on equity of -26.35%.

American Shared Hospital Services has a consensus price target of $4.84, signalling upside risk potential of 74.73%. On the other hand P3 Health Partners has an analysts' consensus of $16.25 which suggests that it could grow by 82.79%. Given that P3 Health Partners has higher upside potential than American Shared Hospital Services, analysts believe P3 Health Partners is more attractive than American Shared Hospital Services.

American Shared Hospital Services has a beta of 0.424, which suggesting that the stock is 57.593% less volatile than S&P 500. In comparison P3 Health Partners has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. P3 Health Partners offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. P3 Health Partners pays out -- of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7M, which are smaller than P3 Health Partners quarterly revenues of $362.1M. American Shared Hospital Services's net income of -$207K is higher than P3 Health Partners's net income of -$46.5M. Notably, American Shared Hospital Services's price-to-earnings ratio is 7.94x while P3 Health Partners's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.64x versus 0.02x for P3 Health Partners. Usually stocks with elevated PS ratios are considered overvalued.